Literature DB >> 16297158

Selective expansion of CD16highCCR2- subpopulation of circulating monocytes with preferential production of haem oxygenase (HO)-1 in response to acute inflammation.

K Mizuno1, T Toma, H Tsukiji, H Okamoto, H Yamazaki, K Ohta, K Ohta, Y Kasahara, S Koizumi, A Yachie.   

Abstract

Monocytes are composed of two distinct subpopulations in the peripheral blood as determined by their surface antigen expressions, profiles of cytokine production and functional roles played in vivo. We attempted to delineate the unique functional roles played by a minor CD16(high)CCR2(-) subpopulation of circulating monocytes. They produced significant levels of interleukin (IL)-6 and tumour necrosis factor (TNF)-alpha, but very low levels of IL-10 upon in vitro stimulation. Characteristic profiles of cytokine production were confirmed by stimulating purified subpopulations of monocytes after cell sorting. It was noteworthy that freshly isolated CD16(high)CCR2(-) monocyte subpopulations produced significant levels of haem oxygenase (HO)-1, whereas the major CD16(low)CCR2(+) subpopulation produced little. These results were contrary to the generally accepted notion that the CD16(high)CCR2(-) monocyte subpopulation plays a predominantly proinflammatory role in vivo. The CD16(high)CCR2(-) subpopulation increased in Kawasaki disease and influenza virus infection. In accord with this, HO-1 mRNA expression by mononuclear cells was significantly increased in these illnesses. These results indicate that CD16(high)CCR2(-) subpopulations are of a distinct lineage from CD16(low)CCR2(+) monocytes. More importantly, they may represent a monocyte subpopulation with a unique functional role to regulate inflammation by producing HO-1 in steady state in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297158      PMCID: PMC1809529          DOI: 10.1111/j.1365-2249.2005.02932.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Heme oxygenase: protective gene or Trojan horse.

Authors:  J L Platt; K A Nath
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

2.  Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway.

Authors:  L E Otterbein; F H Bach; J Alam; M Soares; H Tao Lu; M Wysk; R J Davis; R A Flavell; A M Choi
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

3.  Expression of heme oxygenase-1 can determine cardiac xenograft survival.

Authors:  M P Soares; Y Lin; J Anrather; E Csizmadia; K Takigami; K Sato; S T Grey; R B Colvin; A M Choi; K D Poss; F H Bach
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

4.  Reduced stress defense in heme oxygenase 1-deficient cells.

Authors:  K D Poss; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: role of secreted MCP-1 in the regulation of the chemotactic response.

Authors:  L Fantuzzi; P Borghi; V Ciolli; G Pavlakis; F Belardelli; S Gessani
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

6.  Upregulation of heme oxygenase-1 gene by turpentine oil-induced localized inflammation: involvement of interleukin-6.

Authors:  Kyrylo Tron; Ruslan Novosyadlyy; Jozsef Dudas; Anatoly Samoylenko; Thomas Kietzmann; Giuliano Ramadori
Journal:  Lab Invest       Date:  2005-03       Impact factor: 5.662

7.  Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency.

Authors:  A Yachie; Y Niida; T Wada; N Igarashi; H Kaneda; T Toma; K Ohta; Y Kasahara; S Koizumi
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

8.  Heme oxygenase: a novel target for the modulation of the inflammatory response.

Authors:  D Willis; A R Moore; R Frederick; D A Willoughby
Journal:  Nat Med       Date:  1996-01       Impact factor: 53.440

9.  CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection.

Authors:  N Thieblemont; L Weiss; H M Sadeghi; C Estcourt; N Haeffner-Cavaillon
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

10.  Potential role of heme oxygenase-1 in the progression of rat adjuvant arthritis.

Authors:  Isabel Devesa; Maria Luisa Ferrándiz; Isabel Guillén; José Miguel Cerdá; Maria José Alcaraz
Journal:  Lab Invest       Date:  2005-01       Impact factor: 5.662

View more
  21 in total

Review 1.  The multiple roles of monocyte subsets in steady state and inflammation.

Authors:  Clinton S Robbins; Filip K Swirski
Journal:  Cell Mol Life Sci       Date:  2010-05-01       Impact factor: 9.261

2.  Changes of monocyte subsets in patients with acute coronary syndrome and correlation with myocardial injury markers.

Authors:  Li Zhu; Yigang Yin; Ruifang Zhou; Jie Lin; Jianming Li; Jun Ye
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 3.  Patrolling monocytes in sickle cell hemolytic conditions.

Authors:  Y Liu; H Zhong; F Vinchi; A Mendelson; K Yazdanbakhsh
Journal:  Transfus Clin Biol       Date:  2019-02-22       Impact factor: 1.406

4.  Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection.

Authors:  Lucio Gama; Erin N Shirk; Julia N Russell; Karina I Carvalho; Ming Li; Suzanne E Queen; Jorge Kalil; M Christine Zink; Janice E Clements; Esper G Kallas
Journal:  J Leukoc Biol       Date:  2012-02-24       Impact factor: 4.962

5.  Clonotypic analysis of T cell reconstitution after haematopoietic stem cell transplantation (HSCT) in patients with severe combined immunodeficiency.

Authors:  H Okamoto; C Arii; F Shibata; T Toma; T Wada; M Inoue; Y Tone; Y Kasahara; S Koizumi; Y Kamachi; Y Ishida; J Inagaki; M Kato; T Morio; A Yachie
Journal:  Clin Exp Immunol       Date:  2007-03-21       Impact factor: 4.330

6.  HO-1hi patrolling monocytes protect against vaso-occlusion in sickle cell disease.

Authors:  Yunfeng Liu; Fangmiao Jing; Woelsung Yi; Avital Mendelson; Patricia Shi; Ronald Walsh; David F Friedman; Caterina Minniti; Deepa Manwani; Stella T Chou; Karina Yazdanbakhsh
Journal:  Blood       Date:  2018-02-02       Impact factor: 22.113

7.  CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.

Authors:  Baoying Liu; Ashwin Dhanda; Sima Hirani; Emily L Williams; H Nida Sen; Fernando Martinez Estrada; Diamond Ling; Ian Thompson; Megan Casady; Zhiyu Li; Han Si; William Tucker; Lai Wei; Shayma Jawad; Amol Sura; Jennifer Dailey; Susan Hannes; Ping Chen; Jason L Chien; Siamon Gordon; Richard W J Lee; Robert B Nussenblatt
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

8.  Impaired functions of peripheral blood monocyte subpopulations in aged humans.

Authors:  Joseph Nyugen; Sudhanshu Agrawal; Sastry Gollapudi; Sudhir Gupta
Journal:  J Clin Immunol       Date:  2010-08-12       Impact factor: 8.317

9.  Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage.

Authors:  Woong-Ki Kim; Yue Sun; Hien Do; Patrick Autissier; Elkan F Halpern; Michael Piatak; Jeffrey D Lifson; Tricia H Burdo; Michael S McGrath; Kenneth Williams
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

10.  Hemin controls T cell polarization in sickle cell alloimmunization.

Authors:  Hui Zhong; Weili Bao; David Friedman; Karina Yazdanbakhsh
Journal:  J Immunol       Date:  2014-05-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.